Stock Photo - SCK chairman of the board Derick-Philippe Gosselin poses for the photographer during a Press moment of the nuclear research center SCK CEN and the National Institute for Radioelements IRE on the scaling up of the production of lutetium-177, in Brussels, Friday 25 February 2022. By increasing the supply, both partners provide numerous cancer patients access to effective treatment and thus life-saving care. The radioisotope is promising for the treatment of prostate cancer, among other things. The production facility will be on the SCK CEN site in Mol, while IRE will effectively bring the radioisotopes to the patient. This next step is today ratified with an official signature BELGA PHOTO JAMES ARTHUR GEKIERE.